Modus Therapeutics Holding AB (publ) (STO:MODTX)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.2980
+0.0050 (1.71%)
Mar 5, 2026, 9:51 AM CET

STO:MODTX Cash Flow Statement

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-18.54-15.55-17.9-18.32-20.69
Other Operating Activities
0.41-01.50.31-
Change in Accounts Receivable
-0.48-0.13-0.3-0.35
Change in Other Net Operating Assets
0.060.39-0.15-3.414.96
Operating Cash Flow
-18.08-14.68-16.68-21.72-16.08
Other Investing Activities
-----0.05
Investing Cash Flow
-----0.05
Short-Term Debt Issued
--711.5-
Total Debt Issued
--711.5-
Net Debt Issued (Repaid)
--711.5-
Issuance of Common Stock
--19.37-33
Other Financing Activities
25.07--1.05--3.57
Financing Cash Flow
25.07-25.3211.529.43
Net Cash Flow
6.99-14.688.64-10.2213.3
Cash Interest Paid
----0
Levered Free Cash Flow
-11.33-9.03-11.32-14.86-8.32
Unlevered Free Cash Flow
-11.33-9.03-10.38-14.66-8.32
Change in Working Capital
0.060.87-0.29-3.724.61
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.